| Completed | GITMO AML/MDS-Relapse Registry Study Acute Myeloid Leukaemia, Myelodysplastic Syndrome | — | 2022-12-15 |
| Completed | Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma Multiple Myeloma, Stem Cell Transplant | — | 2021-12-17 |
| Completed | Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT Hematologic Diseases, Stem Cell Transplant Complications, Cytomegalovirus Viremia | — | 2021-01-01 |
| Completed | Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies Myeloid Malignancies | Phase 2 | 2020-01-15 |
| Active Not Recruiting | Venetoclax and Decitabine Assessment in Patients (≥60 - <75 Years) with Newly Diagnosed AML Eligible for Allo- Acute Myeloid Leukemia | Phase 2 | 2019-12-09 |
| Active Not Recruiting | Pentaglobin in CRE and PA Neutropenic Infections Septic Shock | Phase 2 | 2019-12-06 |
| Completed | ALLO-SCT in Elderly Patients With Hematological Disease Hematologic Diseases, Stem Cell Transplant Complications | — | 2019-04-01 |
| Completed | DSAs in Patients Undergoing Allo-HSCT From Mismatched Donors Hematologic Diseases, Stem Cell Transplant Complications | — | 2018-10-15 |
| Completed | High Resolution Donor Recipient HLA Matching Level in Unrelated HSCT Hematologic Diseases | — | 2017-09-01 |
| Completed | A Prospective Observational Study for Evaluating CGVHD Chronic Graft-Versus-Host Disease | — | 2017-09-01 |
| Completed | Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant Complications of Organ Transplant Stem Cells, Gram-Negative Bacterial Infections | — | 2014-01-01 |
| Completed | A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia Acute Leukemia | Phase 2 | 2013-07-01 |
| Completed | Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD Chronic Graft Versus Host Disease | Phase 1 | 2011-11-01 |
| Completed | Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myel Myelofibrosis | Phase 2 | 2011-07-01 |
| Completed | Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogene Acute Myeloid Leukemia (AML) | Phase 3 | 2008-01-01 |
| Completed | Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant Acute Myeloblastic Leukemia, Lymphoblastic Leukemia, Myelodysplasia | Phase 2 / Phase 3 | 2005-03-01 |